Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016, Article ID 3690628, 23 pages
http://dx.doi.org/10.1155/2016/3690628
Review Article

Emerging Comorbidities in Adult Asthma: Risks, Clinical Associations, and Mechanisms

1Department of Respiratory Medicine, Seinäjoki Central Hospital, 60220 Seinäjoki, Finland
2Department of Respiratory Medicine, University of Tampere, 33521 Tampere, Finland
3Department of Respiratory Medicine and Allergology, Skin and Allergy Hospital, Helsinki University Hospital and Helsinki University, 00029 Helsinki, Finland

Received 11 September 2015; Revised 1 December 2015; Accepted 2 December 2015

Academic Editor: Anshu Agrawal

Copyright © 2016 Hannu Kankaanranta et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. To, S. Stanojevic, G. Moores et al., “Global asthma prevalence in adults: findings from the cross-sectional world health survey,” BMC Public Health, vol. 12, article 204, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. S. B. de Nijs, L. N. Venekamp, and E. H. Bel, “Adult-onset asthma: is it really different?” European Respiratory Review, vol. 22, no. 127, pp. 44–52, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. S. E. Wenzel, “Asthma phenotypes: the evolution from clinical to molecular approaches,” Nature Medicine, vol. 18, no. 5, pp. 716–725, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Ilmarinen, L. E. Tuomisto, and H. Kankaanranta, “Phenotypes, risk factors, and mechanisms of adult-onset asthma,” Mediators of Inflammation, vol. 2015, Article ID 514868, 19 pages, 2015. View at Publisher · View at Google Scholar
  5. H. Bisgaard and K. Bonnelykke, “Long-term studies of the natural history of asthma in childhood,” Journal of Allergy and Clinical Immunology, vol. 126, no. 2, pp. 187–197, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Rönmark, A. Lindberg, L. Watson, and B. Lundbäck, “Outcome and severity of adult onset asthma—report from the obstructive lung disease in northern Sweden studies (OLIN),” Respiratory Medicine, vol. 101, no. 11, pp. 2370–2377, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. L. E. Tuomisto, P. Ilmarinen, and H. Kankaanranta, “Prognosis of new-onset asthma diagnosed at adult age,” Respiratory Medicine, vol. 109, no. 8, pp. 944–954, 2015. View at Publisher · View at Google Scholar
  8. A. Sood, C. Qualls, M. Schuyler et al., “Adult-onset asthma becomes the dominant phenotype among women by age 40 years: the longitudinal CARDIA study,” Annals of the American Thoracic Society, vol. 10, no. 3, pp. 188–197, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. C. C. Imes and L. E. Burke, “The obesity epidemic: the United States as a cautionary tale for the rest of the world,” Current Epidemiology Reports, vol. 1, no. 2, pp. 82–88, 2014. View at Publisher · View at Google Scholar
  10. K. Barnett, S. W. Mercer, M. Norbury, G. Watt, S. Wyke, and B. Guthrie, “Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study,” The Lancet, vol. 380, no. 9836, pp. 37–43, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Pache, P. Vollenweider, G. Waeber, and P. Marques-Vidal, “Prevalence of measured and reported multimorbidity in a representative sample of the Swiss population,” BMC Public Health, vol. 15, article 164, 2015. View at Publisher · View at Google Scholar
  12. S. W. Mercer, “Comorbidity in asthma is important and requires a generalist approach,” Primary Care Respiratory Journal, vol. 23, no. 1, pp. 4–5, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. J. M. Spergel, “From atopic dermatitis to asthma: the atopic march,” Annals of Allergy, Asthma and Immunology, vol. 105, no. 2, pp. 99–106, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Bousquet, J. M. Anto, P. Demoly et al., “Severe chronic allergic (and related) diseases: a uniform approach—a MeDALL—GA2LEN—ARIA position paper,” International Archives of Allergy and Immunology, vol. 158, no. 3, pp. 216–231, 2012. View at Google Scholar
  15. C. A. Akdis, C. Bachert, C. Cingi et al., “Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology,” Journal of Allergy and Clinical Immunology, vol. 131, no. 6, pp. 1479–1490, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. L. F. Eichenfield, W. L. Tom, S. L. Chamlin et al., “Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis,” Journal of the American Academy of Dermatology, vol. 70, no. 2, pp. 338–351, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. D. P. Guh, W. Zhang, N. Bansback, Z. Amarsi, C. L. Birmingham, and A. H. Anis, “The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis,” BMC Public Health, vol. 9, article 88, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. L.-P. Boulet and M.-È. Boulay, “Asthma-related comorbidities,” Expert Review of Respiratory Medicine, vol. 5, no. 3, pp. 377–393, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. D. K. Ledford and R. F. Lockey, “Asthma and comorbidities,” Current Opinion in Allergy and Clinical Immunology, vol. 13, no. 1, pp. 78–86, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Cazzola, A. Segreti, L. Calzetta, and P. Rogliani, “Comorbidities of asthma: current knowledge and future research needs,” Current Opinion in Pulmonary Medicine, vol. 19, no. 1, pp. 36–41, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Kauppi, H. Kupiainen, A. Lindqvist et al., “Overlap syndrome of asthma and COPD predicts low quality of life,” Journal of Asthma, vol. 48, no. 3, pp. 279–285, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. Global Initiative for Asthma, Global Strategy for Asthma Management and Prevention, 2014, http://www.ginasthma.org.
  23. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2014, http://www.goldcopd.org/.
  24. M. Miravitlles, J. J. Soler-Cataluña, M. Calle et al., “Guía Española de la EPOC (GesEPOC). Tratamiento farmacológico de la EPOC estable,” Archivos de Bronconeumología, vol. 48, no. 7, pp. 247–257, 2012. View at Publisher · View at Google Scholar
  25. H. Kankaanranta, T. Harju, M. Kilpeläinen et al., “Diagnosis and pharmacotherapy of stable chronic obstructive pulmonary disease: the finnish guidelines,” Basic & Clinical Pharmacology and Toxicology, vol. 116, no. 4, pp. 291–307, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Miravitlles, J. J. Soler-Cataluña, M. Calle et al., “A new approach to grading and treating COPD based on clinical phenotypes: summary of the Spanish COPD guidelines (GesEPOC),” Primary Care Respiratory Journal, vol. 22, no. 1, pp. 117–121, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. Ø. Karlstad, P. Nafstad, A. Tverdal, S. Skurtveit, and K. Furu, “Comorbidities in an asthma population 8–29 years old: a study from the Norwegian Prescription Database,” Pharmacoepidemiology and Drug Safety, vol. 21, no. 10, pp. 1045–1052, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. A. S. Gershon, C. Wang, J. Guan, and T. To, “Burden of comorbidity in individuals with asthma,” Thorax, vol. 65, no. 7, pp. 612–618, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. A. S. Gershon, J. Guan, C. Wang, J. C. Victor, and T. To, “Describing and quantifying asthma comorbidty: a population study,” PLoS ONE, vol. 7, no. 5, Article ID e34967, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. J. B. Soriano, G. T. Visick, H. Muellerova, N. Payvandi, and A. L. Hansell, “Patterns of comorbidities in newly diagnosed COPD and asthma in primary care,” Chest, vol. 128, no. 4, pp. 2099–2107, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Kankaanranta, A. Lahdensuo, E. Moilanen, and P. J. Barnes, “Add-on therapy options in asthma not adequately controlled by inhaled corticosteroids: a comprehensive review,” Respiratory Research, vol. 5, article 17, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Suissa, A. Kezouh, and P. Ernst, “Inhaled corticosteroids and risks of diabetes onset and progression,” American Journal of Medicine, vol. 123, no. 11, pp. 1001–1006, 2010. View at Publisher · View at Google Scholar
  33. K. Mattishent, M. Thavarajah, P. Blanco, D. Gilbert, A. M. Wilson, and Y. K. Loke, “Meta-review: adverse effects of inhaled corticosteroids relevant to older patients,” Drugs, vol. 74, no. 5, pp. 539–547, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. H. Steppuhn, U. Langen, T. Keil, and C. Scheidt-Nave, “Chronic disease co-morbidity of asthma and unscheduled asthma care among adults: results of the national telephone health interview survey German health update (GEDA) 2009 and 2010,” Primary Care Respiratory Journal, vol. 23, no. 1, pp. 22–29, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Hakola, P. Kauppi, T. Leino et al., “Persistent asthma, comorbid conditions and the risk of work disability: a prospective cohort study,” Allergy, vol. 66, no. 12, pp. 1598–1603, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. D. Gibeon, K. Batuwita, M. Osmond et al., “Obesity-associated severe asthma represents a distinct clinical phenotype. Analysis of the british thoracic society difficult asthma registry patient cohort according to BMI,” Chest, vol. 143, no. 2, pp. 406–414, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. Z. Ali and C. S. Ulrik, “Obesity and asthma: a coincidence or a causal relationship? A systematic review,” Respiratory Medicine, vol. 107, no. 9, pp. 1287–1300, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. P. Sivapalan, Z. Diamant, and C. S. Ulrik, “Obesity and asthma: current knowledge and future needs,” Current Opinion in Pulmonary Medicine, vol. 21, no. 1, pp. 80–85, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. L. Wang, K. Wang, X. Gao, T. K. Paul, J. Cai, and Y. Wang, “Sex difference in the association between obesity and asthma in U.S. adults: findings from a national study,” Respiratory Medicine, vol. 109, no. 8, pp. 955–962, 2015. View at Publisher · View at Google Scholar
  40. B. Brumpton, A. Langhammer, P. Romundstad, Y. Chen, and X.-M. Mai, “General and abdominal obesity and incident asthma in adults: the HUNT study,” European Respiratory Journal, vol. 41, no. 2, pp. 323–329, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. N. Assad, C. Qualls, L. J. Smith et al., “Body mass index is a stronger predictor than the metabolic syndrome for future asthma in women. The longitudinal CARDIA study,” American Journal of Respiratory and Critical Care Medicine, vol. 188, no. 3, pp. 319–326, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Ruotsalainen, V. Sidoroff, E. Piippo-Savolainen, M. K. Hyvärinen, and M. Korppi, “Association between overweight and asthma or allergy: results from a prospective 27-year post-bronchiolitis follow-up,” Current Pediatric Research, vol. 16, no. 2, pp. 95–100, 2012. View at Google Scholar · View at Scopus
  43. J. I. Peters, J. M. McKinney, B. Smith, P. Wood, E. Forkner, and A. D. Galbreath, “Impact of obesity in asthma: evidence from a large prospective disease management study,” Annals of Allergy, Asthma and Immunology, vol. 106, no. 1, pp. 30–35, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Pakhale, S. Doucette, K. Vandemheen et al., “A comparison of obese and nonobese people with asthma: exploring an asthma-obesity interaction,” Chest, vol. 137, no. 6, pp. 1316–1323, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Scott, J. Currie, P. Albert, P. Calverley, and J. P. H. Wilding, “Risk of misdiagnosis, health-related quality of life, and BMI in patients who are overweight with doctor-diagnosed asthma,” Chest, vol. 141, no. 3, pp. 616–624, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Lessard, H. Turcotte, Y. Cormier, and L.-P. Boulet, “Obesity and asthma: a specific phenotype?” Chest, vol. 134, no. 2, pp. 317–323, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. F. Holguin, E. R. Bleecker, W. W. Busse et al., “Obesity and asthma: an association modified by age of asthma onset,” Journal of Allergy and Clinical Immunology, vol. 127, no. 6, pp. 1486.e2–1493.e2, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. D. Gibeon, K. Batuwita, M. Osmond et al., “Obesity-associated severe asthma represents a distinct clinical phenotype analysis of the british thoracic society diffi cult asthma registry patient cohort according to BMI,” Chest, vol. 143, no. 2, pp. 406–414, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. A. Bruno, E. Pace, F. Cibella, and P. Chanez, “Body mass index and comorbidities in adult severe asthmatics,” BioMed Research International, vol. 2014, Article ID 607192, 7 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  50. A. K. Ramasamy, N. Gupta, and R. Kumar, “Impact of obesity on bronchial asthma in Indian population,” Lung India, vol. 31, no. 2, pp. 121–126, 2014. View at Publisher · View at Google Scholar
  51. G. Ciprandi, I. Schiavetti, R. B. Fontana, V. Sorbello, and F. L. M. Ricciardolo, “Overweight and obesity as risk factors for impaired lung function in patients with asthma: a real-life experience,” Allergy and Asthma Proceedings, vol. 35, no. 4, pp. e62–e71, 2014. View at Publisher · View at Google Scholar · View at Scopus
  52. B. Taylor, D. Mannino, C. Brown, D. Crocker, N. Twum-Baah, and F. Holguin, “Body mass index and asthma severity in the National Asthma Survey,” Thorax, vol. 63, no. 1, pp. 14–20, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. J. E. Cotes, D. J. Chinn, and J. W. Reed, “Body mass, fat percentage, and fat free mass as reference variables for lung function: effects on terms for age and sex,” Thorax, vol. 56, no. 11, pp. 839–844, 2001. View at Publisher · View at Google Scholar · View at Scopus
  54. M. S. Biring, M. I. Lewis, J. T. Liu, and Z. Mohsenifar, “Pulmonary physiologic changes of morbid obesity,” The American Journal of the Medical Sciences, vol. 318, no. 5, pp. 293–297, 1999. View at Publisher · View at Google Scholar · View at Scopus
  55. G. N. Bedell, W. R. Wilson, and P. M. Seebohm, “Pulmonary function in obese persons,” Journal of Clinical Investigation, vol. 37, no. 7, pp. 1049–1060, 1958. View at Publisher · View at Google Scholar · View at Scopus
  56. M. Schatz, R. S. Zeiger, S. J. Yang et al., “Prospective study on the relationship of obesity to asthma impairment and risk,” The Journal of Allergy and Clinical Immunology: In Practice, vol. 3, no. 4, pp. 560.e1–565.e1, 2015. View at Publisher · View at Google Scholar
  57. B. Stenius-Aarniala, T. Poussa, J. Kvarnström, E.-L. Grönlund, M. Ylikahri, and P. Mustajoki, “Immediate and long term effects of weight reduction in obese people with asthma: randomised controlled study,” British Medical Journal, vol. 320, no. 7238, pp. 827–832, 2000. View at Publisher · View at Google Scholar · View at Scopus
  58. H. A. Scott, P. G. Gibson, M. L. Garg et al., “Dietary restriction and exercise improve airway inflammation and clinical outcomes in overweight and obese asthma: a randomized trial,” Clinical and Experimental Allergy, vol. 43, no. 1, pp. 36–49, 2013. View at Publisher · View at Google Scholar · View at Scopus
  59. S. Pakhale, J. Baron, R. Dent, K. Vandemheen, and S. D. Aaron, “Effects of weight loss on airway responsiveness in obese adults with asthma. Does weight loss lead to reversibility of asthma?” Chest, vol. 147, no. 6, pp. 1582–1590, 2015. View at Publisher · View at Google Scholar
  60. L.-P. Boulet, H. Turcotte, J. Martin, and P. Poirier, “Effect of bariatric surgery on airway response and lung function in obese subjects with asthma,” Respiratory Medicine, vol. 106, no. 5, pp. 651–660, 2012. View at Publisher · View at Google Scholar · View at Scopus
  61. A. van Huisstede, A. Rudolphus, M. Castro Cabezas et al., “Effect of bariatric surgery on asthma control, lung function and bronchial and systemic inflammation in morbidly obese subjects with asthma,” Thorax, vol. 70, no. 7, pp. 659–667, 2015. View at Publisher · View at Google Scholar
  62. A. E. Dixon, R. E. Pratley, P. M. Forgione et al., “Effects of obesity and bariatric surgery on airway hyperresponsiveness, asthma control and inflammation,” Journal of Allergy and Clinical Immunology, vol. 128, no. 3, pp. 508–515, 2011. View at Publisher · View at Google Scholar · View at Scopus
  63. K. Hasegawa, Y. Tsugawa, Y. Chang, and C. A. Camargo, “Risk of an asthma exacerbation after bariatric surgery in adults,” Journal of Allergy and Clinical Immunology, vol. 136, no. 2, pp. 288–294, 2015. View at Publisher · View at Google Scholar · View at Scopus
  64. J. V. Garmendia, D. Moreno, A. H. García, and J. B. De Sanctis, “Metabolic syndrome and asthma,” Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, vol. 8, no. 1, pp. 60–66, 2014. View at Publisher · View at Google Scholar · View at Scopus
  65. B. M. Brumpton, C. A. Camargo Jr., P. R. Romundstad, A. Langhammer, Y. Chen, and X.-M. Mai, “Metabolic syndrome and incidence of asthma in adults: the HUNT study,” European Respiratory Journal, vol. 42, no. 6, pp. 1495–1502, 2013. View at Publisher · View at Google Scholar · View at Scopus
  66. E. J. Lee, K. H. In, E. S. Ha et al., “Asthma-like symptoms are increased in the metabolic syndrome,” Journal of Asthma, vol. 46, no. 4, pp. 339–342, 2009. View at Publisher · View at Google Scholar · View at Scopus
  67. M. B. Fessler, “Next stop for HDL: the lung,” Clinical and Experimental Allergy, vol. 42, no. 3, pp. 340–342, 2013. View at Publisher · View at Google Scholar · View at Scopus
  68. M. B. Fessler, “Revisiting ‘Good’ and ‘Bad’ cholesterol. The battle over flow through arteries now shifts to flow through airways,” American Journal of Respiratory and Critical Care Medicine, vol. 191, no. 9, pp. 969–970, 2015. View at Publisher · View at Google Scholar
  69. P. L. Enright, B. J. Ward, R. P. Tracy, and E. C. Lasser, “Asthma and its association with cardiovascular disease in the elderly. The carciovascular health study research group,” Journal of Asthma, vol. 33, no. 1, pp. 45–53, 1996. View at Publisher · View at Google Scholar
  70. C. Picado, R. Deulofeu, R. Lleonart et al., “Lipid and protein metabolism in asthma. Effects of diet and corticosteroid therapy,” Allergy, vol. 54, no. 6, pp. 569–575, 1999. View at Publisher · View at Google Scholar · View at Scopus
  71. A. V. Barochia, M. Kaler, R. A. Cuento et al., “Serum apolipoprotein A-I and large high-density lipoprotein particles are positively correlated with FEV1 in atopic asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 191, no. 9, pp. 990–1000, 2015. View at Publisher · View at Google Scholar
  72. S. Dogra, C. I. Ardern, and J. Baker, “The relationship between age of asthma onset and cardiovascular disease in Canadians,” Journal of Asthma, vol. 44, no. 10, pp. 849–854, 2007. View at Publisher · View at Google Scholar · View at Scopus
  73. T. Zhang, B. C. Carleton, R. J. Prosser, and A. M. Smith, “The added burden of comorbidity in patients with asthma,” Journal of Asthma, vol. 46, no. 10, pp. 1021–1026, 2009. View at Publisher · View at Google Scholar · View at Scopus
  74. D. A. Hickson, R. L. Wilhite, M. F. Petrini, W. B. White, and C. Burchfiel, “Asthma and asthma severity among african american adults in the Jackson Heart Study,” Journal of Asthma, vol. 46, no. 4, pp. 421–428, 2009. View at Publisher · View at Google Scholar · View at Scopus
  75. M. Johnson, J. Nriagu, A. Hammad, K. Savoie, and H. Jamil, “Asthma, environmental risk factors, and hypertension among Arab Americans in metro Detroit,” Journal of Immigrant and Minority Health, vol. 12, no. 5, pp. 640–651, 2010. View at Publisher · View at Google Scholar · View at Scopus
  76. S. C. Christiansen, M. Schatz, S.-J. Yang, E. Ngor, W. Chen, and B. L. Zuraw, “Hypertension and asthma: a comorbid relationship,” Journal of Allergy and Clinical Immunology in Practice, vol. 2, pp. S2213–2198, 2015, [Epub ahead of print]. View at Google Scholar
  77. N. Nurminen, S. Oikarinen, and H. Hyöty, “Virus infections as potential targets of preventive treatments for type 1 diabetes,” The Review of Diabetic Studies, vol. 9, no. 4, pp. 260–271, 2012. View at Publisher · View at Google Scholar · View at Scopus
  78. S. F. Ehrlich, C. P. Quesenberry Jr., S. K. Van Den Eeden, J. Shan, and A. Ferrara, “Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer,” Diabetes Care, vol. 33, no. 1, pp. 55–60, 2010. View at Publisher · View at Google Scholar · View at Scopus
  79. S. F. Thomsen, D. L. Duffy, K. O. Kyvik, A. Skytthe, and V. Backer, “Risk of asthma in adult twins with type 2 diabetes and increased body mass index,” Allergy, vol. 66, no. 4, pp. 562–568, 2011. View at Publisher · View at Google Scholar · View at Scopus
  80. M. Hashemzadeh and M. R. Movahed, “The occurrence of asthma in hospitalized patients with type 2 diabetes mellitus,” Internal Medicine Journal, vol. 39, no. 10, pp. 699–701, 2009. View at Publisher · View at Google Scholar · View at Scopus
  81. N. T. Mueller, W.-P. Koh, A. O. Odegaard, M. D. Gross, J.-M. Yuan, and M. A. Pereira, “Asthma and the risk of type 2 diabetes in the Singapore Chinese Health Study,” Diabetes Research and Clinical Practice, vol. 99, no. 2, pp. 192–199, 2013. View at Publisher · View at Google Scholar · View at Scopus
  82. P. M. O'Byrne, S. Rennard, H. Gerstein et al., “Risk of new onset diabetes mellitus in patients with asthma or COPD taking inhaled corticosteroids,” Respiratory Medicine, vol. 106, no. 11, pp. 1487–1493, 2012. View at Publisher · View at Google Scholar · View at Scopus
  83. J. S. Rana, M. A. Mittleman, J. Sheikh et al., “Chronic obstructive pulmonary disease, asthma, and risk of type 2 diabetes in women,” Diabetes Care, vol. 27, no. 10, pp. 2478–2484, 2004. View at Publisher · View at Google Scholar · View at Scopus
  84. Y. Song, A. Klevak, J. E. Manson, J. E. Buring, and S. Liu, “Asthma, chronic obstructive pulmonary disease, and type 2 diabetes in the Women's Health Study,” Diabetes Research and Clinical Practice, vol. 90, no. 3, pp. 365–371, 2010. View at Publisher · View at Google Scholar · View at Scopus
  85. H. D. Yun, E. Knoebel, Y. Fenta et al., “Asthma and proinflammatory conditions: a population-based retrospective matched cohort study,” Mayo Clinic Proceedings, vol. 87, no. 10, pp. 953–960, 2012. View at Publisher · View at Google Scholar · View at Scopus
  86. K. Torén and N. B. Lindholm, “Do patients with severe asthma run an increased risk from ischaemic heart disease?” International Journal of Epidemiology, vol. 25, no. 3, pp. 617–620, 1996. View at Publisher · View at Google Scholar · View at Scopus
  87. V. Bellia, C. Pedone, F. Catalano et al., “Asthma in the elderly: mortality rate and associated risk factors for mortality,” Chest, vol. 132, no. 4, pp. 1175–1182, 2007. View at Publisher · View at Google Scholar · View at Scopus
  88. H. M. Lee, S. T. Truong, and N. D. Wong, “Association of adult-onset asthma with specific cardiovascular conditions,” Respiratory Medicine, vol. 106, no. 7, pp. 948–953, 2012. View at Publisher · View at Google Scholar · View at Scopus
  89. C. Iribarren, I. V. Tolstykh, and M. D. Eisner, “Are patients with asthma at increased risk of coronary heart disease?” International Journal of Epidemiology, vol. 33, no. 4, pp. 743–748, 2004. View at Publisher · View at Google Scholar · View at Scopus
  90. M. Szklo, R. Barnes, A. Folsom et al., “The atherosclerosis risk in communities (ARIC) study: design and objectives,” American Journal of Epidemiology, vol. 129, no. 4, pp. 687–702, 1989. View at Google Scholar · View at Scopus
  91. J. G. Schanen, C. Iribarren, E. Shahar et al., “Asthma and incident cardiovascular disease: the Atherosclerosis Risk in Communities study,” Thorax, vol. 60, no. 8, pp. 633–638, 2005. View at Publisher · View at Google Scholar · View at Scopus
  92. S. Onufrak, J. Abramson, and V. Vaccarino, “Adult-onset asthma is associated with increased carotid atherosclerosis among women in the atherosclerosis risk in communities (ARIC) study,” Atherosclerosis, vol. 195, no. 1, pp. 129–137, 2007. View at Publisher · View at Google Scholar · View at Scopus
  93. S. J. Onufrak, J. L. Abramson, H. D. Austin, F. Holguin, W. M. McClellan, and L. V. Vaccarino, “Relation of adult-onset asthma to coronary heart disease and stroke,” American Journal of Cardiology, vol. 101, no. 9, pp. 1247–1252, 2008. View at Publisher · View at Google Scholar · View at Scopus
  94. C. Iribarren, I. V. Tolstykh, M. K. Miller, E. Sobel, and M. D. Eisner, “Adult asthma and risk of coronary heart disease, cerebrovascular disease, and heart failure: a prospective study of 2 matched cohorts,” American Journal of Epidemiology, vol. 176, no. 11, pp. 1014–1024, 2012. View at Publisher · View at Google Scholar · View at Scopus
  95. M. C. Tattersall, M. Guo, C. E. Korcarz et al., “Asthma predicts cardiovascular disease events: the multi-ethnic study of atherosclerosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 35, no. 6, pp. 1520–1525, 2015. View at Publisher · View at Google Scholar
  96. Y. Çolak, S. Afzal, B. G. Nordestgaard, and P. Lange, “Characteristics and prognosis of never-smokers and smokers with asthma in the copenhagen general population study. A prospective cohort study,” American Journal of Respiratory and Critical Care Medicine, vol. 192, no. 2, pp. 172–181, 2015. View at Publisher · View at Google Scholar
  97. M. Pujades-Rodriquez, J. George, A. D. Shah et al., “Heterogeneous associations between smoking and a wide range of initial presentations of cardiovascular disease in 1 937 360 people in England: lifetime risks and implications for risk prediction,” International Journal of Epidemiology, vol. 44, no. 1, pp. 129–141, 2015. View at Publisher · View at Google Scholar
  98. J. Garcia-Aymerich, “The role of smoking in the association between asthma and cardiovascular disease. An example of poorly controlled confounding,” American Journal of Respiratory and Critical Care Medicine, vol. 192, no. 2, p. 123, 2015. View at Publisher · View at Google Scholar
  99. M. Opolski and I. Wilson, “Asthma and depression: a pragmatic review of the literature and recommendations for future research,” Clinical Practice and Epidemiology in Mental Health, vol. 1, article 18, 2005. View at Publisher · View at Google Scholar · View at Scopus
  100. T. Ritz, A. E. Meuret, A. F. Trueba, A. Fritzsche, and A. von Leupoldt, “Psychosocial factors and behavioral medicine interventions in asthma,” Journal of Consulting and Clinical Psychology, vol. 81, no. 2, pp. 231–250, 2013. View at Publisher · View at Google Scholar · View at Scopus
  101. K. M. Scott, M. Von Korff, J. Ormel et al., “Mental disorders among adults with asthma: results from the world mental health Survey,” General Hospital Psychiatry, vol. 29, no. 2, pp. 123–133, 2007. View at Publisher · View at Google Scholar · View at Scopus
  102. E. B. Weiser, “The prevalence of anxiety disorders among adults with asthma: a meta-analytic review,” Journal of Clinical Psychology in Medical Settings, vol. 14, no. 4, pp. 297–307, 2007. View at Publisher · View at Google Scholar · View at Scopus
  103. M. Jiang, P. Qin, and X. Yang, “Comorbidity between depression and asthma via immune-inflammatory pathways: a meta-analysis,” Journal of Affective Disorders, vol. 166, pp. 22–29, 2014. View at Publisher · View at Google Scholar · View at Scopus
  104. J. De Miguel Diez, V. Hernandez-Barrera, L. P. Maestu, P. C. Garrido, T. Gomez Garcia, and R. Jimenez Garcia, “Psychiatric comorbidity in asthma patients. Associated factors,” Journal of Asthma, vol. 48, no. 3, pp. 253–258, 2011. View at Publisher · View at Google Scholar · View at Scopus
  105. R. D. Goodwin, F. Jacobi, and W. Thefeld, “Mental disorders and asthma in the community,” Archives of General Psychiatry, vol. 60, no. 11, pp. 1125–1130, 2003. View at Publisher · View at Google Scholar · View at Scopus
  106. C. Q. Jiang, A. Loerbroks, K.-B. H. Lam et al., “Mental health and asthma in China: the Guangzhou Biobank Cohort Study,” International Journal of Behavioral Medicine, vol. 20, no. 2, pp. 259–264, 2013. View at Publisher · View at Google Scholar · View at Scopus
  107. K. O. Wong, B. H. Rowe, J. Douwes, and A. Senthilselvan, “Asthma and wheezing are associated with depression and anxiety in adults: an analysis from 54 countries,” Pulmonary Medicine, vol. 2013, Article ID 929028, 10 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  108. W. J. Katon, L. Richardson, P. Lozano, and E. McCauley, “The relationship of asthma and anxiety disorders,” Psychosomatic Medicine, vol. 66, no. 3, pp. 349–355, 2004. View at Publisher · View at Google Scholar
  109. M. J. Slattery and M. J. Essex, “Specificity in the association of anxiety, depression, and atopic disorders in a community sample of adolescents,” Journal of Psychiatric Research, vol. 45, no. 6, pp. 788–795, 2011. View at Publisher · View at Google Scholar · View at Scopus
  110. I. Olssøn and A. A. Dahl, “Personality problems are considerably associated with somatic morbidity and health care utilisation,” European Psychiatry, vol. 24, no. 7, pp. 442–449, 2009. View at Publisher · View at Google Scholar · View at Scopus
  111. N. Iessa, M. L. Murray, S. Curran, and I. C. K. Wong, “Asthma and suicide-related adverse events: a review of observational studies,” European Respiratory Review, vol. 20, no. 122, pp. 287–292, 2011. View at Publisher · View at Google Scholar · View at Scopus
  112. M. S. Pedersen, M. E. Benros, E. Agerbo, A. D. Børglum, and P. B. Mortensen, “Schizophrenia in patients with atopic disorders with particular emphasis on asthma: a Danish population-based study,” Schizophrenia Research, vol. 138, no. 1, pp. 58–62, 2012. View at Publisher · View at Google Scholar · View at Scopus
  113. K. M. Scott, M. V. Korff, J. Alonso et al., “Childhood adversity, early-onset depressive/anxiety disorders, and adult-onset asthma,” Psychosomatic Medicine, vol. 70, no. 9, pp. 1035–1043, 2008. View at Publisher · View at Google Scholar · View at Scopus
  114. J. Alonso, P. de Jonge, C. C. W. Lim et al., “Association between mental disorders and subsequent adult onset asthma,” Journal of Psychiatric Research, vol. 59, pp. 179–188, 2014. View at Publisher · View at Google Scholar · View at Scopus
  115. N. Hutter, A. Knecht, and H. Baumeister, “Health care costs in persons with asthma and comorbid mental disorders. A systematic review,” General Hospital Psychiatry, vol. 33, no. 5, pp. 443–453, 2011. View at Publisher · View at Google Scholar · View at Scopus
  116. K. L. Lavoie, S. L. Bacon, S. Barone, A. Cartier, B. Ditto, and M. Labrecque, “What is worse for asthma control and quality of life: depressive disorders, anxiety disorders, or both?” Chest, vol. 130, no. 4, pp. 1039–1047, 2006. View at Publisher · View at Google Scholar · View at Scopus
  117. K. L. Lavoie, M. Boudreau, A. Plourde, T. S. Campbell, and S. L. Bacon, “Association between generalized anxiety disorder and asthma morbidity,” Psychosomatic Medicine, vol. 73, no. 6, pp. 504–513, 2011. View at Publisher · View at Google Scholar · View at Scopus
  118. H. Favreau, S. L. Bacon, M. Labrecque, and K. L. Lavoie, “Prospective impact of panic disorder and panic-anxiety on asthma control, health service use, and quality of life in adult patients with asthma over a 4-year follow-up,” Psychosomatic Medicine, vol. 76, no. 2, pp. 147–155, 2014. View at Publisher · View at Google Scholar · View at Scopus
  119. A. ten Brinke, M. E. Ouwerkerk, A. H. Zwinderman, P. Spinhoven, and E. H. Bel, “Psychopathology in patients with severe asthma is associated with increased health care utilization,” American Journal of Respiratory and Critical Care Medicine, vol. 163, no. 5, pp. 1093–1096, 2001. View at Publisher · View at Google Scholar · View at Scopus
  120. K. Ouellet, S. L. Bacon, M. Boudreau, A. Plourde, G. Moullec, and K. L. Lavoie, “Individual and combined impact of cigarette smoking, anxiety, and mood disorders on asthma control,” Nicotine & Tobacco Research, vol. 14, no. 8, pp. 961–969, 2012. View at Publisher · View at Google Scholar · View at Scopus
  121. M. Boudreau, S. L. Bacon, K. Ouellet, A. Jacob, and K. L. Lavoie, “Mediator effect of depressive symptoms on the association between BMI and asthma control in adults,” Chest, vol. 146, no. 2, pp. 348–354, 2014. View at Publisher · View at Google Scholar · View at Scopus
  122. S. G. Kapadia, C. Wei, S. J. Bartlett, J. Lang, R. A. Wise, and A. E. Dixon, “Obesity and symptoms of depression contribute independently to the poor asthma control of obesity,” Respiratory Medicine, vol. 108, no. 8, pp. 1100–1107, 2014. View at Publisher · View at Google Scholar · View at Scopus
  123. M. B. Stein, B. J. Cox, T. O. Afifi, S.-L. Belik, and J. Sareen, “Does co-morbid depressive illness magnify the impact of chronic physical illness? A population-based perspective,” Psychological Medicine, vol. 36, no. 5, pp. 587–596, 2006. View at Publisher · View at Google Scholar · View at Scopus
  124. A. van Huisstede, A. Rudolphus, A. van Schadewijk et al., “Bronchial and systemic inflammation in morbidly obese subjects with asthma: a biopsy study,” American Journal of Respiratory and Critical Care Medicine, vol. 190, no. 8, pp. 951–954, 2014. View at Publisher · View at Google Scholar · View at Scopus
  125. D. Desai, C. Newby, F. A. Symon et al., “Elevated sputum interleukin-5 and submucosal eosinophilia in obese individuals with severe asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 188, no. 6, pp. 657–663, 2013. View at Publisher · View at Google Scholar
  126. I. H. van Veen, A. Ten Brinke, P. J. Sterk, K. F. Rabe, and E. H. Bel, “Airway inflammation in obese and nonobese patients with difficult-to-treat asthma,” Allergy, vol. 63, no. 5, pp. 570–574, 2008. View at Publisher · View at Google Scholar · View at Scopus
  127. T. J. T. Sutherland, J. O. Cowan, S. Young et al., “The association between obesity and asthma: interactions between systemic and airway inflammation,” American Journal of Respiratory and Critical Care Medicine, vol. 178, no. 5, pp. 469–475, 2008. View at Publisher · View at Google Scholar · View at Scopus
  128. W. C. Moore, A. T. Hastie, X. Li et al., “Sputum neutrophil counts are associated with more severe asthma phenotypes using cluster analysis,” The Journal of Allergy and Clinical Immunology, vol. 133, no. 6, pp. 1557–1563.e5, 2014. View at Publisher · View at Google Scholar · View at Scopus
  129. J. R. O'Reilly and R. M. Reynolds, “The risk of maternal obesity to the long-term health of the offspring,” Clinical Endocrinology, vol. 78, no. 1, pp. 9–16, 2013. View at Publisher · View at Google Scholar · View at Scopus
  130. E. Forno, O. M. Young, R. Kumar, H. Simhan, and J. C. Celedón, “Maternal obesity in pregnancy, gestational weight gain, and risk of childhood asthma,” Pediatrics, vol. 134, no. 2, pp. e535–e546, 2014. View at Publisher · View at Google Scholar · View at Scopus
  131. R. C. Johnson and R. F. Schoeni, “Early-life origins of adult disease: national longitudinal population-based study of the United States,” American Journal of Public Health, vol. 101, no. 12, pp. 2317–2324, 2011. View at Publisher · View at Google Scholar · View at Scopus
  132. C. J. Smith and K. K. Ryckman, “Epigenetic and developmental influences on the risk of obesity, diabetes, and metabolic syndrome,” Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, vol. 8, pp. 295–302, 2015. View at Google Scholar
  133. P. D. Gluckman, M. A. Hanson, C. Cooper, and K. L. Thornburg, “Effect of in utero and early-life conditions on adult health and disease,” The New England Journal of Medicine, vol. 359, no. 1, pp. 61–73, 2008. View at Publisher · View at Google Scholar · View at Scopus
  134. A. Danese, T. E. Moffitt, C. M. Pariante, A. Ambler, R. Poulton, and A. Caspi, “Elevated inflammation levels in depressed adults with a history of childhood maltreatment,” Archives of General Psychiatry, vol. 65, no. 4, pp. 409–416, 2008. View at Publisher · View at Google Scholar · View at Scopus
  135. G. E. Miller and S. W. Cole, “Clustering of depression and inflammation in adolescents previously exposed to childhood adversity,” Biological Psychiatry, vol. 72, no. 1, pp. 34–40, 2012. View at Publisher · View at Google Scholar · View at Scopus
  136. P. F. Coogan, L. A. Wise, G. T. O'Connor, T. A. Brown, J. R. Palmer, and L. Rosenberg, “Abuse during childhood and adolescence and risk of adult-onset asthma in African American women,” The Journal of Allergy and Clinical Immunology, vol. 131, no. 4, pp. 1058–1063, 2013. View at Publisher · View at Google Scholar · View at Scopus
  137. R. J. Van Lieshout, J. Bienenstock, and G. M. MacQueen, “A review of candidate pathways underlying the association between asthma and major depressive disorder,” Psychosomatic Medicine, vol. 71, no. 2, pp. 187–195, 2009. View at Publisher · View at Google Scholar · View at Scopus
  138. L. G. Wood, K. J. Baines, J. Fu, H. A. Scott, and P. G. Gibson, “The neutrophilic inflammatory phenotype is associated with systemic inflammation in asthma,” Chest, vol. 142, no. 1, pp. 86–93, 2012. View at Publisher · View at Google Scholar · View at Scopus
  139. K. J. Baines, V. Backer, P. G. Gibson, H. Powel, and C. M. Porsbjerg, “Impaired lung function is associated with systemic inflammation and macrophage activation,” The European Respiratory Journal, vol. 45, no. 2, pp. 557–559, 2015. View at Publisher · View at Google Scholar
  140. J. B. Morjaria, K. S. Babu, P. Vijayanand, A. J. Chauhan, D. E. Davies, and S. T. Holgate, “Sputum IL-6 concentrations in severe asthma and its relationship with FEV1,” Thorax, vol. 66, no. 6, p. 537, 2011. View at Publisher · View at Google Scholar · View at Scopus
  141. H. Kankaanranta, P. Ilmarinen, X. Zhang et al., “Tumour necrosis factor-α regulates human eosinophil apoptosis via ligation of TNF-receptor 1 and balance between NF-κB and AP-1,” PLoS ONE, vol. 9, no. 2, Article ID e90298, 2014. View at Publisher · View at Google Scholar · View at Scopus
  142. C. A. Hunter and S. A. Jones, “IL-6 as a keystone cytokine in health and disease,” Nature Immunology, vol. 16, no. 5, pp. 448–457, 2015. View at Publisher · View at Google Scholar
  143. M. Rincon and C. G. Irvin, “Role of IL-6 in asthma and other inflammatory pulmonary diseases,” International Journal of Biological Sciences, vol. 8, no. 9, pp. 1281–1290, 2012. View at Publisher · View at Google Scholar · View at Scopus
  144. C. Irvin, I. Zafar, J. Good et al., “Increased frequency of dual-positive TH2/TH17 cells in bronchoalveolar lavage fluid characterizes a population of patients with severe asthma,” The Journal of Allergy and Clinical Immunology, vol. 134, no. 5, pp. 1175.e7–1186.e7, 2014. View at Publisher · View at Google Scholar · View at Scopus
  145. M. Jagannathan-Bogdan, M. E. McDonnell, H. Shin et al., “Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes,” Journal of Immunology, vol. 186, no. 2, pp. 1162–1172, 2011. View at Publisher · View at Google Scholar · View at Scopus
  146. E. Fabbrini, M. Cella, S. A. McCartney et al., “Association between specific adipose tissue CD4+ T-cell populations and insulin resistance in obese individuals,” Gastroenterology, vol. 145, no. 2, pp. 366.e1–374.e3, 2013. View at Publisher · View at Google Scholar · View at Scopus
  147. V. Schmitt, L. Rink, and P. Uciechowski, “The Th17/Treg balance is disturbed during aging,” Experimental Gerontology, vol. 48, no. 12, pp. 1379–1386, 2013. View at Publisher · View at Google Scholar · View at Scopus
  148. C. Brandenberger, N. Li, D. N. Jackson-Humbles, C. E. Rockwell, J. G. Wagner, and J. R. Harkema, “Enhanced allergic airway disease in old mice is associated with a Th17 response,” Clinical & Experimental Allergy, vol. 44, no. 10, pp. 1282–1292, 2014. View at Publisher · View at Google Scholar
  149. T. Wang, Y. Ji, Y. Yang et al., “Transcriptomic profiling of peripheral blood CD4+ T-cells in asthmatics with and without depression,” Gene, vol. 565, no. 2, pp. 282–287, 2015. View at Publisher · View at Google Scholar
  150. O. J. G. Schiepers, M. C. Wichers, and M. Maes, “Cytokines and major depression,” Progress in Neuro-Psychopharmacology & Biological Psychiatry, vol. 29, no. 2, pp. 201–217, 2005. View at Publisher · View at Google Scholar · View at Scopus
  151. M. C. Wichers and M. Maes, “The role of indoleamine 2,3-dioxygenase (IDO) in the pathophysiology of interferon-alpha-induced depression,” Journal of Psychiatry & Neuroscience, vol. 29, no. 1, pp. 11–17, 2004. View at Google Scholar · View at Scopus
  152. M. Haneklaus and L. A. O'Neill, “NLRP3 at the interface of metabolism and inflammation,” Immunological Reviews, vol. 265, no. 1, pp. 53–62, 2015. View at Publisher · View at Google Scholar
  153. M. Iwata, K. T. Ota, and R. S. Duman, “The inflammasome: pathways linking psychological stress, depression, and systemic illnesses,” Brain, Behavior, and Immunity, vol. 31, pp. 105–114, 2013. View at Publisher · View at Google Scholar · View at Scopus
  154. S. R. Kim, D. I. Kim, S. H. Kim et al., “NLRP3 inflammasome activation by mitochondrial ROS in bronchial epithelial cells is required for allergic inflammation,” Cell Death & Disease, vol. 5, no. 10, Article ID e1498, 2014. View at Publisher · View at Google Scholar
  155. C.-B. Zhu, K. M. Lindler, A. W. Owens, L. C. Daws, R. D. Blakely, and W. A. Hewlett, “Interleukin-1 receptor activation by systemic lipopolysaccharide induces behavioral despair linked to MAPK regulation of CNS serotonin transporters,” Neuropsychopharmacology, vol. 35, no. 13, pp. 2510–2520, 2010. View at Publisher · View at Google Scholar · View at Scopus
  156. S. Ramamoorthy, J. D. Ramamoorthy, P. D. Prasad et al., “Regulation of the human serotonin transporter by interleukin-1β,” Biochemical and Biophysical Research Communications, vol. 216, no. 2, pp. 560–567, 1995. View at Publisher · View at Google Scholar · View at Scopus
  157. H. Y. Kim, H. J. Lee, Y.-J. Chang et al., “Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity,” Nature Medicine, vol. 20, no. 1, pp. 54–61, 2014. View at Publisher · View at Google Scholar · View at Scopus
  158. T. J. T. Sutherland, M. R. Sears, C. R. McLachlan, R. Poulton, and R. J. Hancox, “Leptin, adiponectin, and asthma: findings from a population-based cohort study,” Annals of Allergy, Asthma & Immunology, vol. 103, no. 2, pp. 101–107, 2009. View at Publisher · View at Google Scholar · View at Scopus
  159. M. Canöz, F. Erdenen, H. Uzun, C. Müderrisoglu,, and S. Aydin, “The relationship of inflammatory cytokines with asthma and obesity,” Clinical and Investigative Medicine, vol. 31, no. 6, pp. E373–E379, 2008. View at Google Scholar · View at Scopus
  160. C. E. Ruhl and J. E. Everhart, “Leptin concentrations in the United States: relations with demographic and anthropometric measures,” The American Journal of Clinical Nutrition, vol. 74, no. 3, pp. 295–301, 2001. View at Google Scholar · View at Scopus
  161. O. Sideleva, B. T. Suratt, K. E. Black et al., “Obesity and asthma: an inflammatory disease of adipose tissue not the airway,” American Journal of Respiratory and Critical Care Medicine, vol. 186, no. 7, pp. 598–605, 2012. View at Publisher · View at Google Scholar · View at Scopus
  162. S. A. Shore, I. N. Schwartzman, M. S. Mellema, L. Flynt, A. Imrich, and R. A. Johnston, “Effect of leptin on allergic airway responses in mice,” The Journal of Allergy and Clinical Immunology, vol. 115, no. 1, pp. 103–109, 2005. View at Publisher · View at Google Scholar · View at Scopus
  163. J. H. J. Vernooy, N. D. J. Ubags, G. G. Brusselle et al., “Leptin as regulator of pulmonary immune responses: involvement in respiratory diseases,” Pulmonary Pharmacology & Therapeutics, vol. 26, no. 4, pp. 464–472, 2013. View at Publisher · View at Google Scholar · View at Scopus
  164. S. Leivo-Korpela, L. Lehtimäki, K. Vuolteenaho et al., “Adipokine resistin predicts anti-inflammatory effect of glucocorticoids in asthma,” Journal of Inflammation, vol. 8, article 12, 2011. View at Publisher · View at Google Scholar · View at Scopus
  165. A. Bruno, E. Pace, P. Chanez et al., “Leptin and leptin receptor expression in asthma,” The Journal of Allergy and Clinical Immunology, vol. 124, no. 2, pp. 237.e1–237.e4, 2009. View at Publisher · View at Google Scholar · View at Scopus
  166. J. H. Shin, J. H. Kim, W. Y. Lee, and J. Y. Shim, “The expression of adiponectin receptors and the effects of adiponectin and leptin on airway smooth muscle cells,” Yonsei Medical Journal, vol. 49, no. 5, pp. 804–810, 2008. View at Publisher · View at Google Scholar · View at Scopus
  167. P. Ilmarinen and H. Kankaanranta, “Eosinophil apoptosis as a therapeutic target in allergic asthma,” Basic & Clinical Pharmacology & Toxicology, vol. 114, no. 1, pp. 109–117, 2014. View at Publisher · View at Google Scholar · View at Scopus
  168. S. Conus, A. Bruno, and H.-U. Simon, “Leptin is an eosinophil survival factor,” The Journal of Allergy and Clinical Immunology, vol. 116, no. 6, pp. 1228–1234, 2005. View at Publisher · View at Google Scholar · View at Scopus
  169. H. Lai, N. Lin, Z. Xing, H. Weng, and H. Zhang, “Association between the level of circulating adiponectin and prediabetes: a meta-analysis,” Journal of Diabetes Investigation, vol. 6, no. 4, pp. 416–429, 2015. View at Publisher · View at Google Scholar
  170. A. Sood, C. Qualls, M. Schuyler et al., “Low serum adiponectin predicts future risk for asthma in women,” American Journal of Respiratory and Critical Care Medicine, vol. 186, no. 1, pp. 41–47, 2012. View at Publisher · View at Google Scholar · View at Scopus
  171. A. Sood and S. A. Shore, “Adiponectin, leptin, and resistin in asthma: basic mechanisms through population studies,” Journal of Allergy, vol. 2013, Article ID 785835, 15 pages, 2013. View at Publisher · View at Google Scholar
  172. S. K. Davis, S. Y. Gebreab, R. Xu et al., “Association of adiponectin with type 2 diabetes and hypertension in African American men and women: the Jackson Heart study,” BMC Cardiovascular Disorders, vol. 15, article 13, 2015. View at Publisher · View at Google Scholar
  173. A. Sood, E. Dominic, and C. Qualls, “Serum adiponectin is associated with adverse outcomes of asthma in men but not in women,” Frontiers in Pharmacology, vol. 2, article 55, 2011. View at Publisher · View at Google Scholar
  174. K. M. Ajuwon and M. E. Spurlock, “Adiponectin inhibits LPS-induced NF-κB activation and IL-6 production and increases PPARγ2 expression in adipocytes,” The American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 288, no. 5, pp. R1220–R1225, 2005. View at Publisher · View at Google Scholar · View at Scopus
  175. E. J. Folco, V. Z. Rocha, M. López-Ilasaca, and P. Libby, “Adiponectin inhibits pro-inflammatory signaling in human macrophages independent of interleukin-10,” The Journal of Biological Chemistry, vol. 284, no. 38, pp. 25569–25575, 2009. View at Publisher · View at Google Scholar · View at Scopus
  176. C. M. van Stijn, J. Kim, A. J. Lusis, G. D. Barish, and R. K. Tangirala, “Macrophage polarization phenotype regulates adiponectin receptor expression and adiponectin anti-inflammatory response,” The FASEB Journal, vol. 29, no. 2, pp. 636–649, 2015. View at Publisher · View at Google Scholar
  177. H. A. Periyalil, P. G. Gibson, and L. G. Wood, “Immunometabolism in obese asthmatics: are we there yet?” Nutrients, vol. 5, no. 9, pp. 3506–3530, 2013. View at Publisher · View at Google Scholar · View at Scopus
  178. O. L. Klein, J. A. Krishnan, S. Glick, and L. J. Smith, “Systematic review of the association between lung function and Type 2 diabetes mellitus,” Diabetic Medicine, vol. 27, no. 9, pp. 977–987, 2010. View at Publisher · View at Google Scholar · View at Scopus
  179. B. G. J. Dekkers, D. Schaafsma, T. Tran, J. Zaagsma, and H. Meurs, “Insulin-induced laminin expression promotes a hypercontractile airway smooth muscle phenotype,” American Journal of Respiratory Cell and Molecular Biology, vol. 41, no. 4, pp. 494–504, 2009. View at Publisher · View at Google Scholar · View at Scopus
  180. G. T. McMahon and R. A. Arky, “Inhaled insulin for diabetes mellitus,” The New England Journal of Medicine, vol. 356, no. 5, pp. 497–502, 2007. View at Publisher · View at Google Scholar · View at Scopus
  181. A. Agrawal, U. Mabalirajan, T. Ahmad, and B. Ghosh, “Emerging interface between metabolic syndrome and asthma,” American Journal of Respiratory Cell and Molecular Biology, vol. 44, no. 3, pp. 270–275, 2011. View at Publisher · View at Google Scholar · View at Scopus
  182. S. Singh, Y. S. Prakash, A. Linneberg, and A. Agrawal, “Insulin and the lung: connecting asthma and metabolic syndrome,” Journal of Allergy, vol. 2013, Article ID 627384, 8 pages, 2013. View at Publisher · View at Google Scholar
  183. P. Dandona, A. Aljada, P. Mohanty et al., “Insulin inhibits intranuclear nuclear factor κB and stimulates IκB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect?” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 7, pp. 3257–3265, 2001. View at Publisher · View at Google Scholar · View at Scopus
  184. H. Ghanim, K. Green, S. Abuaysheh et al., “Suppressive effect of insulin on the gene expression and plasma concentrations of mediators of asthmatic inflammation,” Journal of Diabetes Research, vol. 2015, Article ID 202406, 7 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  185. M. Cazzola, L. Calzetta, P. Rogliani et al., “High glucose enhances responsiveness of human airways smooth muscle via the Rho/ROCK pathway,” American Journal of Respiratory Cell and Molecular Biology, vol. 47, no. 4, pp. 509–516, 2012. View at Publisher · View at Google Scholar · View at Scopus
  186. W. W. Chance, C. Rhee, C. Yilmaz et al., “Diminished alveolar microvascular reserves in type 2 diabetes reflect systemic microangiopathy,” Diabetes Care, vol. 31, no. 8, pp. 1596–1601, 2008. View at Publisher · View at Google Scholar · View at Scopus
  187. H. O. Koskela, P. H. Salonen, and L. Niskanen, “Hyperglycaemia during exacerbations of asthma and chronic obstructive pulmonary disease,” Clinical Respiratory Journal, vol. 7, no. 4, pp. 382–389, 2013. View at Publisher · View at Google Scholar · View at Scopus
  188. E. Gulcan, I. Bulut, A. Toker, and A. Gulcan, “Evaluation of glucose tolerance status in patients with asthma bronchiale,” Journal of Asthma, vol. 46, no. 2, pp. 207–209, 2009. View at Publisher · View at Google Scholar · View at Scopus
  189. K. P. Dawson, A. C. Penna, and P. Manglick, “Acute asthma, salbutamol and hyperglycaemia,” Acta Paediatrica, vol. 84, no. 3, pp. 305–307, 1995. View at Publisher · View at Google Scholar · View at Scopus
  190. P. M. O'Byrne, S. Rennard, H. Gerstein et al., “Risk of new onset diabetes mellitus in patients with asthma or COPD taking inhaled corticosteroids,” Respiratory Medicine, vol. 106, no. 11, pp. 1487–1493, 2012. View at Publisher · View at Google Scholar · View at Scopus
  191. A. G. Desai, A. Togias, C. Schechter, B. Fisher, A. Parow, and G. Skloot, “Peripheral airways dysfunction in obesity reflects increased bronchomotor tone,” The Journal of Allergy and Clinical Immunology, vol. 135, no. 3, pp. 820–822, 2015. View at Publisher · View at Google Scholar
  192. A. Al-Alwan, J. H. T. Bates, D. G. Chapman et al., “The Nonallergic asthma of obesity: a matter of distal lung compliance,” American Journal of Respiratory and Critical Care Medicine, vol. 189, no. 12, pp. 1494–1502, 2014. View at Publisher · View at Google Scholar · View at Scopus
  193. J. H. T. Bates and A. E. Dixon, “Potential role of the airway wall in the asthma of obesity,” Journal of Applied Physiology, vol. 118, no. 1, pp. 36–41, 2015. View at Publisher · View at Google Scholar · View at Scopus
  194. A. Agrawal and Y. S. Prakash, “Obesity, metabolic syndrome, and airway disease: a bioenergetic problem?” Immunology and Allergy Clinics of North America, vol. 34, no. 4, pp. 785–796, 2014. View at Publisher · View at Google Scholar · View at Scopus
  195. A. Gardner, A. Johansson, R. Wibom et al., “Alterations of mitochondrial function and correlations with personality traits in selected major depressive disorder patients,” Journal of Affective Disorders, vol. 76, no. 1–3, pp. 55–68, 2003. View at Publisher · View at Google Scholar · View at Scopus
  196. C. C. Chang, S. H. Jou, T. T. Lin, T. Lai, C. Liu, and Y. Bai, “Mitochondria DNA change and oxidative damage in clinically stable patients with major depressive disorder,” PLoS ONE, vol. 10, no. 5, Article ID e0125855, 2015. View at Publisher · View at Google Scholar
  197. M. K. Montgomery and N. Turner, “Mitochondrial dysfunction and insulin resistance: an update,” Endocrine Connections, vol. 4, no. 1, pp. R1–R15, 2014. View at Publisher · View at Google Scholar
  198. K. F. Petersen, D. Befroy, S. Dufour et al., “Mitochondrial dysfunction in the elderly: possible role in insulin resistance,” Science, vol. 300, no. 5622, pp. 1140–1142, 2003. View at Publisher · View at Google Scholar · View at Scopus
  199. U. Mabalirajan, A. K. Dinda, S. Kumar et al., “Mitochondrial structural changes and dysfunction are associated with experimental allergic asthma,” The Journal of Immunology, vol. 181, no. 5, pp. 3540–3548, 2008. View at Publisher · View at Google Scholar · View at Scopus
  200. L. Aguilera-Aguirre, A. Bacsi, A. Saavedra-Molina, A. Kurosky, S. Sur, and I. Boldogh, “Mitochondrial dysfunction increases allergic airway inflammation,” The Journal of Immunology, vol. 183, no. 8, pp. 5379–5387, 2009. View at Publisher · View at Google Scholar · View at Scopus
  201. E. K. Larkin, Y.-T. Gao, T. Gebretsadik et al., “New risk factors for adult-onset incident asthma. A nested case-control study of host antioxidant defense,” American Journal of Respiratory and Critical Care Medicine, vol. 191, no. 1, pp. 45–53, 2015. View at Publisher · View at Google Scholar · View at Scopus
  202. I. Palomo, A. Contreras, L. M. Alarcón et al., “Elevated concentration of asymmetric dimethylarginine (ADMA) in individuals with metabolic syndrome,” Nitric Oxide: Biology and Chemistry, vol. 24, no. 4, pp. 224–228, 2011. View at Publisher · View at Google Scholar · View at Scopus
  203. J. A. Scott, M. L. North, M. Rafii et al., “Asymmetric dimethylarginine is increased in asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 184, no. 7, pp. 779–785, 2011. View at Publisher · View at Google Scholar · View at Scopus
  204. K. Krzyzanowska, F. Mittermayer, H.-P. Kopp, M. Wolzt, and G. Schernthaner, “Weight loss reduces circulating asymmetrical dimethylarginine concentrations in morbidly obese women,” The Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 12, pp. 6277–6281, 2004. View at Publisher · View at Google Scholar · View at Scopus
  205. M. A. Mcevoy, P. Schofield, W. Smith et al., “Serum methylarginines and incident depression in a cohort of older adults,” Journal of Affective Disorders, vol. 151, no. 2, pp. 493–499, 2013. View at Publisher · View at Google Scholar · View at Scopus
  206. M. L. Selley, “Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression,” Journal of Affective Disorders, vol. 80, no. 2-3, pp. 249–256, 2004. View at Publisher · View at Google Scholar · View at Scopus
  207. F. Holguin, S. A. A. Comhair, S. L. Hazen et al., “An association between L-arginine/asymmetric dimethyl arginine balance, obesity, and the age of asthma onset phenotype,” American Journal of Respiratory and Critical Care Medicine, vol. 187, no. 2, pp. 153–159, 2013. View at Publisher · View at Google Scholar · View at Scopus
  208. L. Rochette, J. Lorin, M. Zeller et al., “Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?” Pharmacology & Therapeutics, vol. 140, no. 3, pp. 239–257, 2013. View at Publisher · View at Google Scholar · View at Scopus
  209. S. M. Wells and A. Holian, “Asymmetric dimethylarginine induces oxidative and nitrosative stress in murine lung epithelial cells,” American Journal of Respiratory Cell and Molecular Biology, vol. 36, no. 5, pp. 520–528, 2007. View at Publisher · View at Google Scholar · View at Scopus
  210. T. Ahmad, U. Mabalirajan, B. Ghosh, and A. Agrawal, “Altered asymmetric dimethyl arginine metabolism in allergically inflamed mouse lungs,” American Journal of Respiratory Cell and Molecular Biology, vol. 42, no. 1, pp. 3–8, 2010. View at Publisher · View at Google Scholar · View at Scopus
  211. P. Ilmarinen, E. Moilanen, J. S. Erjefält, and H. Kankaanranta, “The polyamine spermine promotes survival and activation of human eosinophils,” The Journal of Allergy and Clinical Immunology, vol. 136, no. 2, pp. 482.e11–484.e11, 2015. View at Publisher · View at Google Scholar · View at Scopus
  212. M. L. North, H. Grasemann, N. Khanna, M. D. Inman, G. M. Gauvreau, and J. A. Scott, “Increased ornithine-derived polyamines cause airway hyperresponsiveness in a mouse model of asthma,” American Journal of Respiratory Cell and Molecular Biology, vol. 48, no. 6, pp. 694–702, 2013. View at Publisher · View at Google Scholar · View at Scopus
  213. Z. Bagi, A. Feher, H. Dou, and Z. Broskova, “Selective up-regulation of arginase-1 in coronary arteries of diabetic patients,” Frontiers in Immunology, vol. 4, article 293, 2013. View at Publisher · View at Google Scholar · View at Scopus
  214. M. L. North, N. Khanna, P. A. Marsden, H. Grasemann, and J. A. Scott, “Functionally important role for arginase 1 in the airway hyperresponsiveness of asthma,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 296, no. 6, pp. L911–L920, 2009. View at Publisher · View at Google Scholar · View at Scopus
  215. R. Spanbroek, R. Gräbner, K. Lötzer et al., “Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 3, pp. 1238–1243, 2003. View at Publisher · View at Google Scholar · View at Scopus
  216. F. Cipollone, A. Mezzetti, M. L. Fazia et al., “Association between 5-lipoxygenase expression and plaque instability in humans,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 8, pp. 1665–1670, 2005. View at Publisher · View at Google Scholar · View at Scopus
  217. C. Pergola, G. Dodt, A. Rossi et al., “ERK-mediated regulation of leukotriene biosynthesis by androgens: a molecular basis for gender differences in inflammation and asthma,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 50, pp. 19881–19886, 2008. View at Publisher · View at Google Scholar · View at Scopus
  218. M. Zaitsu, S.-I. Narita, K. C. Lambert et al., “Estradiol activates mast cells via a non-genomic estrogen receptor-alpha and calcium influx.,” Molecular Immunology, vol. 44, no. 8, pp. 1977–1985, 2007. View at Publisher · View at Google Scholar · View at Scopus
  219. H. Kankaanranta, P. Ilmarinen, T. Kankaanranta, and L. E. Tuomisto, “Seinäjoki Adult Asthma Study (SAAS): a protocol for a 12-year real-life follow-up study of new-onset asthma diagnosed at adult age and treated in primary and specialised care,” NPJ Primary Care Respiratory Medicine, vol. 25, Article ID 15042, 2015. View at Publisher · View at Google Scholar
  220. P. Kirkham and I. Rahman, “Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy,” Pharmacology & Therapeutics, vol. 111, no. 2, pp. 476–494, 2006. View at Publisher · View at Google Scholar · View at Scopus